Eculizumab in atypical haemolytic uraemic syndrome with severe cardiac and neurological involvement

Genetics and Outcome of Atypical Hemolytic Uremic Syndrome: A Nationwide French Series Comparing Children and Adults

(2013) V. Fremeaux-Bacchi et al.   Clinical Journal of the American Society of Nephrology

Complement therapy in atypical haemolytic uraemic syndrome (aHUS)

(2013) Edwin K.S. Wong et al.   MOLECULAR IMMUNOLOGY

Recessive mutations in DGKE cause atypical hemolytic-uremic syndrome

(2013) Mathieu Lemaire et al.   NATURE GENETICS

Terminal Complement Inhibitor Eculizumab in Atypical Hemolytic–Uremic Syndrome

(2013) C.M. Legendre et al.   NEW ENGLAND JOURNAL OF MEDICINE

Neurologic involvement in atypical hemolytic uremic syndrome and successful treatment with eculizumab

(2013) Kaan Gulleroglu et al.   PEDIATRIC NEPHROLOGY

Eculizumab therapy for atypical haemolytic uraemic syndrome due to a gain-of-function mutation of complement factor B

(2013) Rodney D. Gilbert et al.   PEDIATRIC NEPHROLOGY

Use of eculizumab for atypical haemolytic uraemic syndrome and C3 glomerulopathies

(2012) Julien Zuber et al.   Nature Reviews Nephrology

Long-term eculizumab improves clinical outcomes in atypical hemolytic uremic syndrome

(2012) Ramon Vilalta et al.   PEDIATRIC NEPHROLOGY

Eculizumab therapy in a child with hemolytic uremic syndrome and CFI mutation

(2012) F. Semsa Caycı et al.   PEDIATRIC NEPHROLOGY

Neonatal onset atypical hemolytic uremic syndrome successfully treated with eculizumab

(2012) Nesrin Besbas et al.   PEDIATRIC NEPHROLOGY

Eculizumab in the Treatment of Atypical Hemolytic Uremic Syndrome in Infants

(2011) Gema Ariceta et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Eculizumab in Severe Shiga-Toxin–Associated HUS

(2011) Anne-Laure Lapeyraque et al.   NEW ENGLAND JOURNAL OF MEDICINE